Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study.
<h4>Background</h4>Circulating levels of the endogenous inhibitor of nitric oxide synthase, asymmetric dimethylarginine (ADMA), are positively associated with the prevalence of metabolic syndrome (MetS) in cross-sectional investigations. It is unclear if circulating ADMA and other methyl...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ceb4479eea9640919734a6f24a35e397 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ceb4479eea9640919734a6f24a35e397 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ceb4479eea9640919734a6f24a35e3972021-12-02T20:04:43ZAssociations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study.1932-620310.1371/journal.pone.0254577https://doaj.org/article/ceb4479eea9640919734a6f24a35e3972021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0254577https://doaj.org/toc/1932-6203<h4>Background</h4>Circulating levels of the endogenous inhibitor of nitric oxide synthase, asymmetric dimethylarginine (ADMA), are positively associated with the prevalence of metabolic syndrome (MetS) in cross-sectional investigations. It is unclear if circulating ADMA and other methylarginines are associated with incident MetS prospectively.<h4>Methods</h4>We related circulating ADMA, symmetric dimethylarginine (SDMA), L-arginine (ARG) concentrations (measured with a validated tandem mass spectrometry assay) and the ARG/ADMA ratio to MetS and its components in 2914 (cross-sectional analysis, logistic regression; mean age 58 years, 55% women) and 1656 (prospective analysis, Cox regression; mean age 56 years, 59% women) individuals from the Framingham Offspring Study who attended a routine examination.<h4>Results</h4>Adjusting for age, sex, smoking, and eGFR, we observed significant associations of ADMA (direct) and ARG/ADMA (inverse) with odds of MetS (N = 1461 prevalent cases; Odds Ratio [OR] per SD increment 1.13, 95%CI 1.04-1.22; and 0.89, 95%CI 0.82-0.97 for ADMA and ARG/ADMA, respectively). Upon further adjustment for waist circumference, systolic and diastolic blood pressure, glucose, high-density lipoprotein cholesterol, and triglycerides, we observed a positive relation between SDMA and MetS (OR per SD increment 1.15, 95% CI 1.01-1.30) but the other associations were rendered statistically non-significant. We did not observe statistically significant associations between any of the methylarginines and the risk of new-onset MetS (752 incident events) over a median follow-up of 11 years.<h4>Conclusion</h4>It is unclear whether dimethylarginines play an important role in the incidence of cardiometabolic risk in the community, notwithstanding cross-sectional associations. Further studies of larger samples are needed to replicate our findings.Ibrahim Musa YolaCarlee MoserMeredith S DuncanEdzard SchwedhelmDorothee AtzlerRenke MaasJuliane HannemannRainer H BögerRamachandran S VasanVanessa XanthakisPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 9, p e0254577 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Ibrahim Musa Yola Carlee Moser Meredith S Duncan Edzard Schwedhelm Dorothee Atzler Renke Maas Juliane Hannemann Rainer H Böger Ramachandran S Vasan Vanessa Xanthakis Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study. |
description |
<h4>Background</h4>Circulating levels of the endogenous inhibitor of nitric oxide synthase, asymmetric dimethylarginine (ADMA), are positively associated with the prevalence of metabolic syndrome (MetS) in cross-sectional investigations. It is unclear if circulating ADMA and other methylarginines are associated with incident MetS prospectively.<h4>Methods</h4>We related circulating ADMA, symmetric dimethylarginine (SDMA), L-arginine (ARG) concentrations (measured with a validated tandem mass spectrometry assay) and the ARG/ADMA ratio to MetS and its components in 2914 (cross-sectional analysis, logistic regression; mean age 58 years, 55% women) and 1656 (prospective analysis, Cox regression; mean age 56 years, 59% women) individuals from the Framingham Offspring Study who attended a routine examination.<h4>Results</h4>Adjusting for age, sex, smoking, and eGFR, we observed significant associations of ADMA (direct) and ARG/ADMA (inverse) with odds of MetS (N = 1461 prevalent cases; Odds Ratio [OR] per SD increment 1.13, 95%CI 1.04-1.22; and 0.89, 95%CI 0.82-0.97 for ADMA and ARG/ADMA, respectively). Upon further adjustment for waist circumference, systolic and diastolic blood pressure, glucose, high-density lipoprotein cholesterol, and triglycerides, we observed a positive relation between SDMA and MetS (OR per SD increment 1.15, 95% CI 1.01-1.30) but the other associations were rendered statistically non-significant. We did not observe statistically significant associations between any of the methylarginines and the risk of new-onset MetS (752 incident events) over a median follow-up of 11 years.<h4>Conclusion</h4>It is unclear whether dimethylarginines play an important role in the incidence of cardiometabolic risk in the community, notwithstanding cross-sectional associations. Further studies of larger samples are needed to replicate our findings. |
format |
article |
author |
Ibrahim Musa Yola Carlee Moser Meredith S Duncan Edzard Schwedhelm Dorothee Atzler Renke Maas Juliane Hannemann Rainer H Böger Ramachandran S Vasan Vanessa Xanthakis |
author_facet |
Ibrahim Musa Yola Carlee Moser Meredith S Duncan Edzard Schwedhelm Dorothee Atzler Renke Maas Juliane Hannemann Rainer H Böger Ramachandran S Vasan Vanessa Xanthakis |
author_sort |
Ibrahim Musa Yola |
title |
Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study. |
title_short |
Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study. |
title_full |
Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study. |
title_fullStr |
Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study. |
title_full_unstemmed |
Associations of circulating dimethylarginines with the metabolic syndrome in the Framingham Offspring study. |
title_sort |
associations of circulating dimethylarginines with the metabolic syndrome in the framingham offspring study. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/ceb4479eea9640919734a6f24a35e397 |
work_keys_str_mv |
AT ibrahimmusayola associationsofcirculatingdimethylarginineswiththemetabolicsyndromeintheframinghamoffspringstudy AT carleemoser associationsofcirculatingdimethylarginineswiththemetabolicsyndromeintheframinghamoffspringstudy AT meredithsduncan associationsofcirculatingdimethylarginineswiththemetabolicsyndromeintheframinghamoffspringstudy AT edzardschwedhelm associationsofcirculatingdimethylarginineswiththemetabolicsyndromeintheframinghamoffspringstudy AT dorotheeatzler associationsofcirculatingdimethylarginineswiththemetabolicsyndromeintheframinghamoffspringstudy AT renkemaas associationsofcirculatingdimethylarginineswiththemetabolicsyndromeintheframinghamoffspringstudy AT julianehannemann associationsofcirculatingdimethylarginineswiththemetabolicsyndromeintheframinghamoffspringstudy AT rainerhboger associationsofcirculatingdimethylarginineswiththemetabolicsyndromeintheframinghamoffspringstudy AT ramachandransvasan associationsofcirculatingdimethylarginineswiththemetabolicsyndromeintheframinghamoffspringstudy AT vanessaxanthakis associationsofcirculatingdimethylarginineswiththemetabolicsyndromeintheframinghamoffspringstudy |
_version_ |
1718375569169580032 |